Literature DB >> 7843813

Penetration of ciprofloxacin into the human pancreas.

R Isenmann1, H Friess, P Schlegel, K Fleischer, M W Büchler.   

Abstract

The aim of this study was to determine the concentrations of ciprofloxacin in human pancreatic tissue and juice. Concentrations were measured by high-pressure liquid chromatography (HPLC). Two hundred mg of ciprofloxacin were administered as a short i.v. infusion (30 min). The median ciprofloxacin concentrations 140 min (median) after the start of infusion in pancreatic tissue as well as in pancreatic juice were 0.9 mg/kg (mg/l). The penetration ratio was 1.0 for pancreatic tissue and 0.83 for pancreatic juice. With regard to the minimal inhibitory concentrations (MIC) for the respective bacteria, ciprofloxacin seems to be an appropriate drug for the treatment of septic complications in necrotizing pancreatitis. Future clinical trials are necessary to prove this assumption.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843813     DOI: 10.1007/bf01715543

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  23 in total

Review 1.  Extravascular penetration of ciprofloxacin. A review.

Authors:  T Bergan
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Mar-Apr       Impact factor: 2.803

Review 2.  Principles of antibiotic tissue penetration and guidelines for pharmacokinetic analysis.

Authors:  J J Schentag; F M Gengo
Journal:  Med Clin North Am       Date:  1982-01       Impact factor: 5.456

3.  Penetration of ciprofloxacin and ofloxacin into human allograft pancreatic juice.

Authors:  C Brattström; A S Malmborg; G Tydén
Journal:  J Antimicrob Chemother       Date:  1988-08       Impact factor: 5.790

4.  Quinolone resistance. Susceptibility data from a 300-bed community hospital.

Authors:  M F Parry; K B Panzer; M E Yukna
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

5.  Early diagnosis of pancreatic infection by computed tomography-guided aspiration.

Authors:  S G Gerzof; P A Banks; A H Robbins; W C Johnson; S J Spechler; S M Wetzner; J M Snider; R E Langevin; M E Jay
Journal:  Gastroenterology       Date:  1987-12       Impact factor: 22.682

6.  Blood-pancreatic juice barrier to antibiotic excretion.

Authors:  G P Burns; T A Stein; L S Kabnick
Journal:  Am J Surg       Date:  1986-02       Impact factor: 2.565

7.  Human pancreatic tissue concentration of bactericidal antibiotics.

Authors:  M Büchler; P Malfertheiner; H Friess; R Isenmann; E Vanek; H Grimm; P Schlegel; T Friess; H G Beger
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

8.  Ciprofloxacin penetration in pancreatic juice.

Authors:  P Pederzoli; M Falconi; C Bassi; S Vesentini; F Orcalli; F Scaglione; M Solbiati; A Messori; N Martini
Journal:  Chemotherapy       Date:  1987       Impact factor: 2.544

9.  [Pancreatic penetration of antibiotics].

Authors:  K Koch; B Drewelow; S Liebe; R Reding; A K Riethling
Journal:  Chirurg       Date:  1991-04       Impact factor: 0.955

10.  Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.

Authors:  R Paganoni; C Herzog; A Braunsteiner; P Hohl
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

View more
  4 in total

1.  Changes in antibiotic distribution due to pancreatitis.

Authors:  Kent J Fanning; Thomas A Robertson; Johannes B Prins; Michael S Roberts
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

2.  Activity of moxifloxacin, imipenem, and ertapenem against Escherichia coli, Enterobacter cloacae, Enterococcus faecalis, and Bacteroides fragilis in monocultures and mixed cultures in an in vitro pharmacokinetic/pharmacodynamic model simulating concentrations in the human pancreas.

Authors:  Sabine Schubert; Axel Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

Review 3.  Antibiosis of Necrotizing Pancreatitis.

Authors:  Alexander Arlt; Wiebke Erhart; Clemens Schafmayer; Hanns-Christoph Held; Jochen Hampe
Journal:  Viszeralmedizin       Date:  2014-10

4.  Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis.

Authors:  Hye Young Sung; Jin Il Kim; Hyun Jeong Lee; Hyung Jun Cho; Dae Young Cheung; Sung Soo Kim; Se Hyun Cho; Jae Kwang Kim
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.